Basel, Switzerland – 31 January 2022 – Arxada, a leading global specialty chemicals business, announces that Ib Jensen, Chief Financial Officer (CFO), has left the Company as of today to pursue another opportunity. His successor is expected to join the Company in April this year and will be announced in due course.
Jan Kantowsky will serve as interim CFO until the permanent successor is in place. Jan has more than 25 years of experience in operational management roles, specializing in interim management.
Marc Doyle, Chief Executive Officer of Arxada, said:
“I would like to thank Ib for his tremendous contributions over the past three years. Ib played a pivotal role in our divestiture and successful carve-out from Lonza and has guided Arxada through our first stages as an independent company. We are grateful to Ib for his leadership at Arxada and wish him success in his future endeavours.”
Ib Jensen, outgoing Chief Financial Officer of Arxada, added:
“It has been a pleasure to have been a part of Arxada’s transformation journey over the past three years and I am confident of its continued growth in the future.”
– ENDS –
Head of Communications
Tel: +41 61 316 8111
Ann Bartling/Rob Winder
Tel: +44 20 3727 1000
Arxada, formerly part of Lonza Group, is a global specialty chemicals business with a world-class offering in Microbial Control Solutions (‘MCS’) and Specialty Products Solutions (‘SPS’). Arxada provides a broad portfolio of differentiated products targeted at a range of end uses, supported by its leading regulatory capabilities, IP expertise and established track record in R&D.
Arxada’s MCS business is a world leader addressing six target end uses: hygiene, home and personal care, paints and coatings, crop protection, material protection and wood protection. MCS is built on superior regulatory expertise, the broadest set of antimicrobial agents and the widest range of registrations in the world, which are critical to maintaining the integrity of its customers’ products.
Arxada’s unique SPS business provides complex, high-quality technologies and chemistries to customers across a range of industries within its three divisions: performance intermediates and chemicals, composite materials and the custom development and manufacturing organization. The two businesses work closely together to provide complementary expertise and deliver unique, innovative solutions to help customers protect their products from harmful microorganisms, improve health and safety and reduce their environmental footprints.
Arxada has a global footprint spanning 26 production sites and 17 R&D centres, with a world-leading team of 3,800 employees serving customers across a wide range of industries.
Arxada is owned by Bain Capital Private Equity and Cinven.